Business Standard

Strides Pharma Science inks deal with Pharmaceutics to buy 18 ANDAs for US

With access to these products, Strides will significantly expand its niche offerings on its front-end, which has grown multi-fold to attain a quarterly revenue size of $66 million

Pharma, medicine, drugs, Pharmaceuticals
Premium

Press Trust of India
Strides Pharma Science on Friday said its arm had entered into a pact with Pharmaceutics International to acquire 18 abbreviated new drug applications (ANDAs) for the US market. With access to these products, Strides will significantly expand its niche offerings on its front-end, which has grown multi-fold to attain a quarterly revenue size of $66 million.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in